Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wisbiom has developed globally leading proprietary microbial strain libraries, high-throughput anaerobic culturing technology, and digital platforms. It has launched non-pharmaceutical probiotic products for children's height intervention in China and the US market (for autism), with ongoing clinical collaborations on pediatric growth disorders. The company partners with top hospitals like Beijing Children's Hospital and Harvard-affiliated Massachusetts General Hospital for clinical research on targeted microbiome interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 中科微生物.